Molotinib usage and dosage
Molotinib, this innovative drug, shows a unique mechanism of action in the treatment of myelofibrosis. As a new type of oral JAK1/JAK2 and activin a receptor type 1 (ACVR1) inhibitor, it inhibits the activity of these key kinases and penetrates deeply into the cell signaling level to accurately attack the disease.
First, molotinib can inhibitJAK1/JAK2 kinase activity. These two kinases are abnormally active in patients with myelofibrosis, leading to overactivation of the JAK-STAT signaling pathway, thereby promoting the development of the disease. Molotinib binds to these kinases and blocks their activity, thereby cutting off this abnormal signaling pathway and providing strong support for disease control.

Secondly, molotinib also has the ability to inhibitACVR1 activity. ACVR1 is an important cell surface receptor closely related to the control of hepcidin. In patients with myelofibrosis, abnormal activation of ACVR1 can lead to overexpression of hepcidin, which can lead to symptoms such as anemia. Molotinib reduces hepcidin levels by inhibiting ACVR1, thereby improving patients' anemia and improving their quality of life.
Molotinib is available as an oral tablet. The recommended dose is 200 mg orally once daily. Molotinib can be taken with food or alone. Swallow the tablet whole. Do not cut, crush, or chew tablets. If a dose is missed, the next scheduled dose should be taken the next day.
Finally, it needs to be emphasized that the therapeutic effect of molotinib is not achieved overnight. Patients need to insist on taking the medication on time and receive regular examinations and evaluations from doctors. At the same time, if any discomfort or suspected side effects occur during medication, you should report it to your doctor immediately so that the treatment plan can be adjusted in a timely manner and patient safety can be ensured.
To sum up, the usage and dosage of molotinib is a key link to ensure the efficacy and patient safety. Patients should strictly follow the doctor's instructions, take the medicine on time and in the right amount, and pay close attention to changes in physical condition.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)